-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | - | 7.317% | -4.348% | -17.757% | -21.429% | 172.953% | - |
| Vaxart Inc. | -5.200% | 9.012% | 13.464% | -46.809% | -55.490% | -77.082% | -94.340% |
| Larimar Therapeutics Inc. | -2.700% | 3.497% | -16.384% | -47.611% | -20.430% | 2.069% | -82.402% |
News
2 Stocks That Have Turned $10,000 Into More Than $1 Million in 10 Years
If you invest for the long term and are willing to be patient, you can generate life-changing returns. As long as you have the mindset that you're buying and holding for the future rather than
Why Energizer Stock Plunged Today
Shares of Energizer Holdings (NYSE: ENR) declined by more than 18% on Tuesday after the battery producer's profits fell short of investors' expectations.
Image source: Getty Images.
Energizer's net
Lisa Su Just Delivered Incredible News for AMD Stock Investors
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other artificial intelligence stocks. To learn more, check out the short video, consider subscribing,


